REGENERON PHARMACEUTICALS, INC. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
REGENERON PHARMACEUTICALS, INC. (REGN) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One of $5.54 billion as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue · last filed 2026-07-30
- 2026-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $5.54B.
- 2026-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $5.79B.
- 2025-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $5.49B.
- 2025-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One $5.94B.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One as first filed |
|---|---|---|
| 2026-06-30 | $5.54B 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $5.79B 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $5.49B 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $5.94B 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $5.47B 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $5.26B 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $6.52B 10-K · filed 2026-02-04 | |
| 2024-09-30 | $7.78B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $7.89B 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $7.92B 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $8.11B 10-K · filed 2025-02-05 | |
| 2023-09-30 | $7.79B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $7.00B 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $5.04B 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $4.64B 10-K · filed 2024-02-05 | |
| 2022-09-30 | $3.53B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $4.17B 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $3.70B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $2.81B 10-K · filed 2023-02-06 | |
| 2021-09-30 | $2.36B 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.84B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $2.07B 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $1.39B 10-K · filed 2022-02-07 | |
| 2020-09-30 | $1.45B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.15B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $1.80B 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $1.60B 10-K · filed 2021-02-08 | |
| 2019-09-30 | $1.49B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $1.62B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $1.52B 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $1.34B 10-K · filed 2020-02-07 | |
| 2018-09-30 | $1.10B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $765.64M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $605.46M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $593.80M 10-K · filed 2019-02-07 | $593.78M 10-K · filed 2018-02-08 |
| 2017-09-30 | $586.88M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $523.54M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $495.31M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $503.48M 10-K · filed 2018-02-08 | $503.48M 10-K · filed 2017-02-09 |
| 2016-09-30 | $443.88M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $345.58M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $244.97M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $236.12M 10-K · filed 2017-02-09 | |
| 2015-09-30 | $241.06M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $213.69M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $234.26M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $251.76M 10-K · filed 2016-02-11 | |
| 2014-09-30 | $287.74M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $216.77M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $186.28M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $158.38M 10-K · filed 2015-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |